Discover
XFOR
X4 Pharmaceuticals, Inc.
4.22
1 x 3.04
1 x 5.37
bid
ask
+
0.14
3.43%
11:26 AM
timesize
| Ytd | 5.62% | |
| 1y | 113.38% |
4.13
day range
4.30
1.35
52 week range
4.83
| Open | 4.15 | Prev Close | 4.08 | Low | 4.13 | High | 4.30 | Mkt Cap | 398.03M |
| Vol | 245.68K | Avg Vol | 599.03K | EPS | -2.07 | P/E | N/A | Forward P/E | -1.23 |
| Beta | 0.39 | Short Ratio | 8.64 | Inst. Own | 67.66% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 4.09 | 200-d Avg | 3.80 | 1yr Est | 3.05 |
| Income Statement | |||
| Total Revenue | 2.71M | ||
| Revenues (USD) | 2.71M | ||
| Cost of Revenue | 598.00K | ||
| Gross Profit | 2.11M | ||
| Operating Expenses | 22.42M | ||
| Research and Development Expense | 15.45M | ||
| Selling, General and Administrative Expense | 6.97M | ||
| Operating Income | -20.31M | ||
| Interest Expense | 2.13M | ||
| Net Income | -20.24M | ||
| Net Income Common Stock | -20.24M | ||
| Net Income Common Stock (USD) | -20.24M | ||
| Consolidated Income | -20.24M | ||
| Earnings per Basic Share | -0.16 | ||
| Earnings per Basic Share (USD) | -0.16 | ||
| Earnings per Diluted Share | -0.16 | ||
| Earning Before Interest & Taxes (EBIT) | -18.11M | ||
| Earning Before Interest & Taxes (USD) | -18.11M | ||
| Weighted Average Shares | 126.29M | ||
| Weighted Average Shares Diluted | 126.29M | ||
| Balance Sheet | |||
| Cash and Equivalents | 216.91M | ||
| Cash and Equivalents (USD) | 216.91M | ||
| Investments | 16.81M | ||
| Investments Current | 16.81M | ||
| Trade and Non-Trade Receivables | 1.11M | ||
| Current Assets | 241.98M | ||
| Property, Plant & Equipment Net | 1.18M | ||
| Total Assets | 270.28M | ||
| Debt Current | 733.00K | ||
| Total Debt | 77.25M | ||
| Current Liabilities | 23.77M | ||
| Debt Non-Current | 76.52M | ||
| Total Liabilities | 101.83M | ||
| Accumulated Retained Earnings (Deficit) | -614.79M | ||
| Accumulated Other Comprehensive Income | -122.00K | ||
| Shareholders Equity | 168.45M | ||
| Shareholders Equity (USD) | 168.45M | ||
| Assets Non-Current | 28.30M | ||
| Total Debt (USD) | 77.25M | ||
| Deferred Revenue | 1.03M | ||
| Goodwill and Intangible Assets | 26.41M | ||
| Inventory | 4.64M | ||
| Liabilities Non-Current | 78.06M | ||
| Trade and Non-Trade Payables | 5.07M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 597.00K | ||
| Net Cash Flow from Financing | 2.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -365.00K | ||
| Net Cash Flow from Investing | 19.25M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 19.25M | ||
| Net Cash Flow from Operations | -19.60M | ||
| Effect of Exchange Rate Changes on Cash | -20.00K | ||
| Share Based Compensation | 2.41M | ||